Identification of Specific Biomarkers and Pathways in the Treatment Response of Infliximab for Inflammatory Bowel Disease: In-Silico Analysis.

Kaddoura, Rachid; Ghelani, Hardik; Alqutami, Fatma; Altaher, Hala; Hachim, Mahmood; Jan, Reem Kais

Kaddoura, Rachid; Ghelani, Hardik; Alqutami, Fatma; Altaher, Hala; Hachim, Mahmood; Jan, Reem Kais.

Afiliación

Kaddoura R; Department of Basic Science, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.
Ghelani H; Department of Basic Science, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.
Alqutami F; Department of Basic Science, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.
Altaher H; Department of Basic Science, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.
Hachim M; Department of Basic Science, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.
Jan RK; Department of Basic Science, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.

Life (Basel) ; 13(3)2023 Mar 02.

Article en En | MEDLINE | ID: mdl-36983834

Palabras clave

differentially expressed gene analysis; in-silico; inflammatory bowel disease; infliximab treatment response; transcriptomics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Life (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Emiratos Árabes Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google